<?xml version="1.0" encoding="UTF-8"?>
<p>Because of the favorable half-life of the fluorine isotope 
 <sup>18</sup>F (109.8 min), it stands out as a unique atom which is used in positron emission tomography (PET). 
 <sup>18</sup>F became a powerful tool used for detection of various cancer types [
 <xref rid="B9-molecules-25-04677" ref-type="bibr">9</xref>,
 <xref rid="B10-molecules-25-04677" ref-type="bibr">10</xref>,
 <xref rid="B11-molecules-25-04677" ref-type="bibr">11</xref>]. Ojima has introduced fluorine into taxoid anticancer agents and studied their tumor-targeted drug delivery systems [
 <xref rid="B12-molecules-25-04677" ref-type="bibr">12</xref>]. The 3â€²-difluorovinyltaxoids (
 <bold>5</bold>) possess (
 <xref ref-type="fig" rid="molecules-25-04677-f003">Figure 3</xref>) an exceptional potency against human breast, ovarian, colon and pancreatic cancer cell lines three times higher in potency compared to that of paclitaxel against breast cancer cell lines MCF-7 (drug-sensitive) and a multidrug-resistant cell line NCI/ADR (drug-resistant) cancer cell lines respectively. 
</p>
